COVID-19 Clinical Trial
— CognitiveOfficial title:
Investigation of the Effect Of Green Walking and Intelligence Games on the Cognitive Skills of Individuals Between the Ages of 50-70 Survived COVID-19 Disease
Verified date | May 2023 |
Source | Bayburt University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Investigation of the Effect Of Green Walking and Intelligence Games on the Cognitive Skills of Individuals Between the Ages of 50-70 Survived COVID-19 Disease The randomized controlled study to examine the effects of green walking and intelligence games on the cognitive skills of individuals aged 50-70 years who had COVID-19 on an outpatient basis were completed with 40 individuals, 20 of which were in the green walking and intelligence game group and 20 were in the control group.
Status | Completed |
Enrollment | 40 |
Est. completion date | May 17, 2022 |
Est. primary completion date | January 3, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 50 Years to 70 Years |
Eligibility | Inclusion Criteria: - Electronic records and contact information (address, telephone) of individuals who were diagnosed with COVID-19 in Erzincan Tercan State Hospital and whose COVID-19 test became negative within one year after being placed in home quarantine with outpatient treatment, - Individuals are between the ages of 50-70, - A score of 20 or less on the Montreal Cognitive Assessment Scale, - To be at least primary school graduate, - Being residing in the Tercan district of Erzincan, - Being able to perform self-care activities independently, - Good general condition, - Having a smart phone or having a smart phone in one person in the household, - For individuals in the trekking and intelligence game group, for one month It indicates that there is no harm in taking a nature walk for 30 minutes three days a week, having the approval of the physician. - Agreeing to participate in the research. - Exclusion Criteria for Research - Positive COVID-19 (PCR) test result, - Being visually and hearing impaired, - Having a balance problem - Using a cane or walker while walking, - Being dependent on a bed or a wheelchair, - Parkinson's, dementia, Alzheimer's diagnosis, - Getting a diagnosis of cancer, - Having a history of central nervous system disease that may cause cognitive dysfunction (stroke, head trauma, tumor, epilepsy, movement disorder diseases), - Using antipsychotics, antidepressants, mood stabilizers, antiepileptics, benzodiazepines and medications that may interfere with the evaluation, - Having undergone any surgery to prevent walking, - Having a condition that prevents walking (musculoskeletal problems, joint problems, fracture, neuropathy, chronic severe pain, loss of limb). - Exclusion Criteria - Do not be hospitalized for any reason, - Change of residence, emigration, death, - Having an infection that requires isolation, - Worsening of the general condition, - Inclusion in another aerobic exercise program, - Unwillingness to continue research. |
Country | Name | City | State |
---|---|---|---|
Turkey | Erzincan Tercan State Hospital | Erzincan |
Lead Sponsor | Collaborator |
---|---|
Bayburt University | Karadeniz Technical University |
Turkey,
Nouchi R, Taki Y, Takeuchi H, Hashizume H, Nozawa T, Kambara T, Sekiguchi A, Miyauchi CM, Kotozaki Y, Nouchi H, Kawashima R. Brain training game boosts executive functions, working memory and processing speed in the young adults: a randomized controlled t — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Investigation on the Cognitive Skills of Individuals Between the Ages of 50-70 Survived COVID-19 Disease | Examine the effects of green walking and intelligence games on the cognitive skills of individuals aged 50-70 years who had COVID-19 on an outpatient basis were completed with individuals | for a month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT06065033 -
Exercise Interventions in Post-acute Sequelae of Covid-19
|
N/A | |
Completed |
NCT06267534 -
Mindfulness-based Mobile Applications Program
|
N/A | |
Completed |
NCT05047601 -
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
|
Phase 2/Phase 3 | |
Recruiting |
NCT04481633 -
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
|
N/A | |
Recruiting |
NCT05323760 -
Functional Capacity in Patients Post Mild COVID-19
|
N/A | |
Completed |
NCT04537949 -
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
|
Phase 1/Phase 2 | |
Completed |
NCT04612972 -
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
|
Phase 3 | |
Recruiting |
NCT05494424 -
Cognitive Rehabilitation in Post-COVID-19 Condition
|
N/A | |
Active, not recruiting |
NCT06039449 -
A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
|
Phase 3 | |
Enrolling by invitation |
NCT05589376 -
You and Me Healthy
|
||
Completed |
NCT05158816 -
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
|
||
Recruiting |
NCT04341506 -
Non-contact ECG Sensor System for COVID19
|
||
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Completed |
NCT04512079 -
FREEDOM COVID-19 Anticoagulation Strategy
|
Phase 4 | |
Active, not recruiting |
NCT05975060 -
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05542862 -
Booster Study of SpikoGen COVID-19 Vaccine
|
Phase 3 | |
Terminated |
NCT05487040 -
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
|
Phase 1 | |
Withdrawn |
NCT05621967 -
Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation
|
N/A | |
Terminated |
NCT04498273 -
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
|
Phase 3 | |
Active, not recruiting |
NCT06033560 -
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
|